Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Use of B-type natriuretic peptide in the management of hypoxaemic respiratory failure.

Noveanu M, Pargger H, Breidthardt T, Reichlin T, Schindler C, Heise A, Schoenenberger R, Manndorff P, Siegemund M, Mebazaa A, Marsch S, Mueller C.

Eur J Heart Fail. 2011 Feb;13(2):154-62. doi: 10.1093/eurjhf/hfq188. Epub 2010 Oct 29.

2.

Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.

Karmpaliotis D, Kirtane AJ, Ruisi CP, Polonsky T, Malhotra A, Talmor D, Kosmidou I, Jarolim P, de Lemos JA, Sabatine MS, Gibson CM, Morrow D.

Chest. 2007 Apr;131(4):964-71.

3.
4.

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators.

JAMA. 2009 Jan 28;301(4):383-92. doi: 10.1001/jama.2009.2.

PMID:
19176440
5.

Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.

Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M.

Crit Care Med. 2006 Aug;34(8):2140-4.

PMID:
16763507
6.

Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study.

Noveanu M, Breidthardt T, Reichlin T, Gayat E, Potocki M, Pargger H, Heise A, Meissner J, Twerenbold R, Muravitskaya N, Mebazaa A, Mueller C.

Crit Care. 2010;14(6):R198. doi: 10.1186/cc9317. Epub 2010 Nov 3.

7.

B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care.

Burri E, Hochholzer K, Arenja N, Martin-Braschler H, Kaestner L, Gekeler H, Hatziisaak T, Büttiker M, Fräulin A, Potocki M, Breidthardt T, Reichlin T, Socrates T, Twerenbold R, Mueller C.

J Intern Med. 2012 Nov;272(5):504-13. doi: 10.1111/j.1365-2796.2012.02552.x. Epub 2012 Jun 12.

8.

Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.

Mueller C, Laule-Kilian K, Schindler C, Klima T, Frana B, Rodriguez D, Scholer A, Christ M, Perruchoud AP.

Arch Intern Med. 2006 May 22;166(10):1081-7.

PMID:
16717170
9.

Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.

Reynolds EW, Ellington JG, Vranicar M, Bada HS.

Pediatrics. 2004 Nov;114(5):1297-304. Erratum in: Pediatrics. 2005 May;115(5):1454.

PMID:
15520111
10.

How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.

Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Maisel AS.

Am Heart J. 2006 May;151(5):999-1005.

PMID:
16644321
11.

Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.

Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, Gordon G, Bagg W, Oxenham H, Yandle T, Richards M, Sharpe N.

J Am Coll Cardiol. 2003 Nov 19;42(10):1793-800.

12.

[BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].

Valle R, Aspromonte N, Carbonieri E, De Michele G, Di Tano G, Giovinazzo P, Cioè R, Di Giacomo T, Milani L, Noventa F, Chiatto M.

Monaldi Arch Chest Dis. 2007 Sep;68(3):154-64. Italian.

PMID:
18361212
13.

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.

Ledwidge M, Gallagher J, Conlon C, Tallon E, O'Connell E, Dawkins I, Watson C, O'Hanlon R, Bermingham M, Patle A, Badabhagni MR, Murtagh G, Voon V, Tilson L, Barry M, McDonald L, Maurer B, McDonald K.

JAMA. 2013 Jul 3;310(1):66-74. doi: 10.1001/jama.2013.7588.

PMID:
23821090
14.

B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.

Lokuge A, Lam L, Cameron P, Krum H, de Villiers S, Bystrzycki A, Naughton MT, Eccleston D, Flannery G, Federman J, Schneider HG.

Circ Heart Fail. 2010 Jan;3(1):104-10. doi: 10.1161/CIRCHEARTFAILURE.109.869438. Epub 2009 Nov 20.

15.

Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.

Lowenthal A, Camacho BV, Lowenthal S, Natal-Hernandez L, Liszewski W, Hills NK, Fineman JR, Bernstein HS.

Am J Cardiol. 2012 Mar 15;109(6):866-72. doi: 10.1016/j.amjcard.2011.10.049. Epub 2011 Dec 22.

16.

Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.

Boldanova T, Noveanu M, Breidthardt T, Potocki M, Reichlin T, Taegtmeyer A, Christ M, Laule K, Stelzig C, Mueller C.

Int J Cardiol. 2010 Jul 23;142(3):265-72. doi: 10.1016/j.ijcard.2008.12.214. Epub 2009 Jan 29.

PMID:
19185372
17.

Primary results of the HABIT Trial (heart failure assessment with BNP in the home).

Maisel A, Barnard D, Jaski B, Frivold G, Marais J, Azer M, Miyamoto MI, Lombardo D, Kelsay D, Borden K, Iqbal N, Taub PR, Kupfer K, Clopton P, Greenberg B.

J Am Coll Cardiol. 2013 Apr 23;61(16):1726-35. doi: 10.1016/j.jacc.2013.01.052. Epub 2013 Mar 26.

18.

Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.

Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, Ikonomidis I, Ilias I, Armaganidis A, Orfanos SE, Dimopoulou I.

Shock. 2009 Apr;31(4):342-7. doi: 10.1097/SHK.0b013e31818635b6.

PMID:
18791494
19.

B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.

Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L.

J Card Fail. 2008 Apr;14(3):219-24. doi: 10.1016/j.cardfail.2007.10.009.

PMID:
18381185
20.

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP.

N Engl J Med. 2004 Feb 12;350(7):647-54.

Supplemental Content

Support Center